CBmed Technologies bridges scientific research and patient care by integrating world-class infrastructure, medical expertise, and global industry partnerships. Specializing in precision medicine, CBmed focuses on identifying and validating new biomarkers through collaborations with leading biobanks, such as Biobank Graz and BBMRI-ERIC.

Our multi-platform, multi-omics research enables deeper insights into biomarker discovery, contributing to personalized clinical decision-making. With advanced lab management systems and a pioneering drug screening platform using patient-derived tumor models, CBmed is accelerating personalized therapies and drug development, driving impactful innovations in healthcare.